Taylor Farms was vindicated in the short-term but it may have lost the thing it can't buy back
Every CCO should be studying what happened between Friday and this morning in the cyclospora outbreak. In four days we got a complete crisis-comms curriculum: a consumer brand turning a health scare into a loyalty rally, a supplier absorbing reputational damage based on evidence that didn't hold up, and, over the weekend, one of the most questionable opening lines I've ever seen in a corporate crisis statement.
Quick recap. A cyclosporiasis outbreak the CDC has tied to shredded iceberg lettuce served at Taco Bell locations in five states (1,644 confirmed cases, 94 hospitalizations, no deaths) became a national story last week. Friday, the FDA's traceback named Taylor Farms as the supplier. Taylor Farms pulled all central-Mexico iceberg and recalled product across 27 states - some of the recalled bags had already reached Walmart shelves and Jack in the Box kitchens, per Consumer Reports. Taco Bell announced the affected lettuce was gone and posted a notes-app Instagram statement — "You always got us. We always got you. See you in the drive-thru. 💜" — that pulled 355K likes and 147K shares, under a comment section that reads like a fan convention ("Explosive diarrhea didn't stop me before, it won't stop me now" is a real, verbatim top comment).
Then Sunday, the FDA reversed its lab result: the one positive Cyclospora test on Taylor Farms lettuce was a false positive. Late last ight, Taylor Farms published an updated statement that opens, verbatim:
"Today, FDA apologized to us."
Not the recall, which is still active. Not the people who are sick (which does eventually appear in the statement, but well down the page). Worth noting is that an apology appears nowhere in the FDA's own public statement. So the apology is Taylor Farms' characterization of a private conversation, and by Monday morning it appears to be working on the earned media side: UPI and Fox Business headlines were about the FDA's mistake, not the outbreak. Taylor Farms is suddenly a sympathetic party in a news cycle it had been losing badly for 72 hours. Measure Monday by Monday, and that statement is a win.
But I don't think you should measure Monday by Monday. Six takeaways from this (so far):
Taco Bell won this weekend on credit it built years ago. Taco Bell got inside the first news cycle with product pulled, statement out, supplier named and every subsequent headline took on that initial frame: Taco Bell was decisive, Taylor Farms was the source. But speed alone didn't produce a comment section joking about explosive diarrhea and pledging loyalty despite everything. Years of ironic, self-aware community-building did. So this is one great example of brand equity being crisis insurance when it counts.
Owned channels beat press releases but only if you write for the channel. Taylor Farms reposted its media statement to social word for word, so the audience with the least patience for corporate content got exactly that. Taco Bell wrote a separate, customer-facing note for the same slot, and that's the version the public absorbed. You can read the difference in the comment sections: Taco Bell's fill with loyalty jokes, Taylor Farms' with conspiracy theories about a Trump payoff for this "FDA apology." Sending the same paragraph to every audience hands your story to whoever's most motivated to reframe it.
Blame flows upstream, so supplier brands need a downstream plan. Taylor Farms have no consumer relationship, no fandom, no direct line to the shopper and ultimately no way to metabolize this hit all. So if grocers are posting their own produce-aisle signs reassuring shoppers about what they are carrying, the narrative has officially left your hands. If you're a B2B or ingredient brand, war-game the day your biggest customer's comms team points at you because they will.
The "again" tax compounds and this was literally "again." This wasn't Taylor Farms' first time as the named supplier in a fast-food outbreak. In October 2024, the onions in the McDonald's Quarter Pounder E. coli outbreak were Taylor Farms'. Same company, twenty months apart. A second incident from the same supplier doesn't get covered as an incident; it gets covered as a pattern.
Leading with your vindication tells everyone what you value. Put yourself in Taylor Farms' seat Sunday night: three brutal days as the named source, and then the regulator admits its only physical evidence was wrong. The anger is completely understandable but the recall is still active, the FDA is still working to pull product, and the epidemiologic and traceback data still converge on Taylor Farm's lettuce. "Today, FDA apologized to us" opens on a vindication the evidence doesn't support and quite honestly hands a plaintiff's attorney a quote about where the company's attention went while people were still in the hospital.
Corrections don't land unless you make them. Sunday's false-positive reversal ran mostly in trade and health press until Taylor Farms forced it into the mainstream with that statement. Credit where it's due... they understood that a correction nobody amplifies is a correction that never happened. So the instinct was right but the execution and sequencing was tone deaf.
The best crisis comms this weekend did its most aggressive work while sounding like a love letter to customers; the most defensive comms did its most self-damaging work while being, on the narrow facts, correct. Which leaves the question Taylor Farms will be answering for a while: when the evidence finally clears you but the trust doesn't, what was the statement actually for?
The chairman talking down his own record prices
SK hynix is having the kind of year most companies only dream about. It makes the high-bandwidth memory that AI systems can't run without, there's nowhere near enough of it to go around, and SK hynix makes more than half the world's supply, around 58 percent of it last quarter, better than double what either of its two biggest rivals manages. Customers are asking for as much as twice the AI memory next year that they're taking this year, prices through the roof.
So it was a strange thing to watch the head of its parent company, chairman Chey Tae-won, stand up at a business forum in Korea last Wednesday and call those same sky-high prices "abnormal." Prices have to normalize, he said, or the market shrinks and competitors flood in. On the surface, the man sitting on the scarcest resource in tech just argued for his own boom to cool off.
Read his reasoning, though, and there's nothing self-sacrificing about it. His case is that prices this high push PC and phone makers into "chipflation" and choke off the demand underneath him, lure in new entrants (he pointed to Musk's interest in chipmaking as an early sign) and eventually turn a supply crunch into a political fight. "Right now, companies absorb the pressure," he said. "Governments will start pressuring other governments soon." So he isn't volunteering to earn less; he's betting that a little restraint now protects the franchise for years. It helps that he also chairs Korea's main business chamber, so "our prices are too high" comes out sounding like a statesman worrying about the whole economy rather than a salesman offering a discount.
Any time your company is the obvious winner of a squeeze like, say, a shortage, a price spike, a rival's collapse, you run the risk of looking like you're profiting off everyone else's pain. In a shortage, the villain is always whoever's holding the scarce thing and smiling. The instinct is to keep your head down and ride it out, and that's the trap. Naming the downside out loud, "yes, this is unsustainable, and here's why that worries me too" reads like getting out ahead of the story instead of waiting to become it.
But the move only works when it's true, and this is where most people trying it come unstuck. Chey can say the prices are abnormal because his interests and the market's health point the same direction: normalize now, or lose the market later AND because he's already spending against it. His company had committed about $14.5 billion to new fabs.
So my advice, if your company is the one winning while everyone else is struggling: don't just grab hold of the humble line to look good. Use it only when the risk you're naming threatens you too and you're already doing something about it: building, spending, cutting, take your pick. Then say it flat and point at the work. If there's no work to point at, stay quiet, because the customers you're reassuring will remember every word and go looking for the receipts.